Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine.

[1]  M. Billah,et al.  Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor. , 2002, European journal of pharmacology.

[2]  C. Suh,et al.  Significant association of FcɛRIα promoter polymorphisms with aspirin-intolerant chronic urticaria , 2007 .

[3]  M. Maurer,et al.  The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo‐ controlled treatment with rupatadine 10 and 20 mg , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  Honghao Zhou,et al.  Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria. , 2014, Journal of dermatological science.

[5]  P. Bradding,et al.  CRACM/Orai ion channel expression and function in human lung mast cells , 2012, The Journal of allergy and clinical immunology.

[6]  Yusuke Nakamura,et al.  ORAI1 Genetic Polymorphisms Associated with the Susceptibility of Atopic Dermatitis in Japanese and Taiwanese Populations , 2012, PloS one.

[7]  T. Zuberbier,et al.  How to assess disease activity in patients with chronic urticaria? , 2008, Allergy.

[8]  O. Kalayci,et al.  Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria , 2012, Archives of Dermatological Research.

[9]  T. Zuberbier,et al.  The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.

[10]  H. Schünemann,et al.  EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.

[11]  M. Sánchez-Borges,et al.  Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing? , 2013, Journal of investigational allergology & clinical immunology.

[12]  J. Billingsley,et al.  Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release–activated calcium channels , 2008, Nature Immunology.

[13]  G. Nilsson,et al.  Molecular targets on mast cells and basophils for novel therapies. , 2014, The Journal of allergy and clinical immunology.

[14]  Honghao Zhou,et al.  Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients , 2015, Archives of Dermatological Research.

[15]  S. Feske.  Calcium signalling in lymphocyte activation and disease , 2007, Nature Reviews Immunology.